BWA
IRMD icon

Basecamp Wealth Advisors’s iRadimed IRMD Stock Holding History

Basecamp Wealth Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.7K Hold
394
– – 0.01% 620
2026
Q1 		$37.9K Hold
394
– – 0.01% 625
2025
Q4 		$38.3K Buy
+394
New +$33.8K 0.01% 597

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Basecamp Wealth Advisors's IRMD Position: Q2 2026 in Review

Basecamp Wealth Advisors held its iRadimed (IRMD) position steady in Q2 2026 at 394 shares worth $37.7K. The position accounts for 0.01% of the portfolio, ranked #620.

Basecamp Wealth Advisors first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $38.3K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Basecamp Wealth Advisors held 394 shares of iRadimed worth $37.7K as of Q2 2026.
  • Basecamp Wealth Advisors left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up 0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #620 holding.
  • Basecamp Wealth Advisors first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's iRadimed position peaked at $38.3K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.